2022
DOI: 10.1016/j.annonc.2022.04.217
|View full text |Cite
|
Sign up to set email alerts
|

P-127 Multi-institutional analysis of real-world activity and safety of trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles